Form 4: Aspen Aerogels Director Receives Annual Equity Grant
Statement of Changes in Beneficial Ownership
Director Cari Robinson was granted restricted stock units and stock options as part of Aspen Aerogels' annual non-employee director compensation policy.
Summary
- Director Cari Robinson received an equity grant on May 13, 2026.
- The grant consisted of 10,370 Restricted Stock Units (RSUs).
- The grant also included 8,706 stock options with an exercise price of $5.40.
- The total beneficial ownership following the transaction is 22,616 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Standardized compensation practice consistent with the company's non-employee director policy.
Negatives
- Dilutive impact of new equity grants, though standard for corporate governance.
Risks
- Market volatility affecting the value of the granted stock options and RSUs.
Future Outlook
The equity grants are scheduled to vest on May 13, 2027, or the day prior to the 2027 annual meeting of stockholders, whichever occurs first.
Management Comments
- The grants were issued pursuant to the Issuer's Non-Employee Director Compensation Policy.
Industry Context
StockSavvy.ai notes that this is a routine disclosure of director compensation, which is standard practice for publicly traded companies to ensure board alignment with long-term shareholder value.
Comparison to Industry Standards
- The use of a mix of RSUs and stock options for director compensation is consistent with standard corporate governance practices in the materials and manufacturing sectors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Authorization for Glenn Deegan and Andrew Lauzon to file SEC documents on behalf of the director. | 2025-09-22 | Administrative update to facilitate regulatory compliance. |
Stakeholder Impact
- Minimal impact on shareholders as this is a standard compensation event.
Next Steps
- Vesting of equity grants on May 13, 2027.
Key Dates
| Date | Description |
|---|---|
| 2025-09-22 | Execution date of the Power of Attorney for SEC filings. |
| 2026-05-13 | Date of the equity grant transaction. |
| 2027-05-13 | Vesting date for RSUs and stock options. |
| 2036-05-13 | Expiration date for the granted stock options. |
Keywords
Aspen Aerogels, ASPN, Form 4, Director Compensation, Equity Grant, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.